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Abstract
P2X7 is a homotrimeric ion channel with two transmembrane domains and a large extracellular ATP-binding domain. It
plays a key role in the response of immune cells to danger signals released from cells at sites of inflammation. Gating of
murine P2X7 can be induced by the soluble ligand ATP, as well as by NAD+-dependent ADP-ribosylation of arginine 125,
a posttranslational protein modification catalyzed by the toxin-related ecto-enzymes ART2.1 and ART2.2. R125 is located at
the edge of the ligand-binding crevice. Recently, an alternative splice variant of P2X7, designated P2X7(k), was discovered
that differs from the previously described variant P2X7(a) in the N-terminal 42 amino acid residues composing the first
cytosolic domain and most of the Tm1 domain. Here we compare the two splice variants of murine P2X7 with respect to
their sensitivities to gating by ADP-ribosylation in transfected HEK cells. Our results show that the P2X7(k) variant is sensitive
to activation by ADP-ribosylation whereas the P2X7(a) variant is insensitive, despite higher cell surface expression levels.
Interestingly, a single point mutation (R276K) renders the P2X7(a) variant sensitive to activation by ADP-ribosylation.
Residue 276 is located at the interface of neighboring subunits approximately halfway between the ADP-ribosylation site
and the transmembrane domains. Moreover, we show that naive and regulatory T cells preferentially express the more
sensitive P2X7(k) variant, while macrophages preferentially express the P2X7(a) variant. Our results indicate that differential
splicing of alternative exons encoding the N-terminal cytosolic and transmembrane domains of P2X7 control the sensitivity
of different immune cells to extracellular NAD+ and ATP.
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Following their release from damaged cells, ATP and NAD+
function as danger signals that alert cells of the immune system
and guide them to sites of tissue damage [1,2]. In the extracellular
compartment these nucleotides act as ligands for receptors and
substrates for ecto-enzymes [3,4]. P2X7 is a homotrimeric ion
channel that can be activated by both, ATP and NAD+ [5,6,7].
While ATP acts as a soluble ligand, activation of P2X7 by NAD+ is
mediated by the toxin-related ADP-ribosyltransferases ART2.1
and ART2.2. These ecto-enzymes catalyze the transfer of an
ADP-ribose moiety from NAD+ to arginine 125 (R125) near the
ATP-binding site of P2X7, while releasing nicotinamide [8,9].
ART2.1 and ART2.2 are encoded by tandem genes on mouse
chromosome 7. ART2.1 is expressed predominantly by macro-
phages and displays high enzyme activity only in the presence of
extracellular thiols [10,11]. ART2.2 is expressed predominantly by
T cells and appears to be constitutively active [12,13].
Naive T cells and in particular CD4+CD25+Foxp3+ regulatory
T cells are highly sensitive to gating of P2X7 by ADP-ribosylation
even at low micromolar concentrations of extracelluar NAD+
[14,15]. This allows influx of Ca2+ and efflux of K+, and induces
a cascade of prominent downstream reactions, including the rapid
externalization of phosphatidylserine, ADAM-metalloprotease
mediated shedding of L-selectin/CD62L, formation of a mem-
brane pore permeable to large molecules (,900 Da) including
DNA-staining dyes, and ultimately results in T cell death [16,17].
A commonly used strain of mice, C57BL/6, carries an allelic
variant of P2X7 that encodes a single point mutation (P451L)
located in the long cytosolic domain of P2X7. This mutation
impedes some of the downstream effector functions induced by
gating of P2X7 [18,19,20]. C57BL/6 mice also carry a rare allelic
variant of the ART2.1 gene, harboring a premature stop codon
that prevents expression [21].
While analyzing nucleotide-induced activation of P2X7 in
transfected HEK cells, we have previously made some intriguing
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observations [8]. In HEK cells co-transfected with cDNA
constructs for P2X7 and ART2.2 or ART2.1, all of these effects
could be induced by, albeit very high, concentrations of ATP, but
none of them could be induced by NAD+ [8,22]. Moreover, when
analyzing the effect of a range of arginine to lysine mutations, that
were originally generated in the extracellular domain of P2X7 to
identify the target sites for ADP-ribosylation, we serendipitously
discovered that three of these single mutants (R206K, R276K and
R277K) could be activated by NAD+-dependent ADP-ribosylation
[8,9]. These same mutants also showed a much lower threshold for
activation by ATP. The properties of these "gain of function"
mutations were reminiscent of the P2X7 responses observed in
murine T cells. In contrast, P2X7 on murine macrophages, akin to
P2X7 on HEK cells, could be gated only by high concentrations of
ATP but not by ADP-ribosylation [22].
Recently, an alternative splice variant of P2X7 was discovered
in rat and mouse [23]. This splice variant, designated P2X7(k),
differs from the previously described variant P2X7(a) in the N-
terminal 42 amino acid residues composing the N-terminal
cytosolic domain and most of the Tm1 domain (Fig. 1). The rat
P2X7(k) variant was shown to be more sensitive to the P2X7
agonist Bz-ATP, have a slower deactivation time upon removal of
agonist, and to have a higher propensity to form pores [23]. Here,
we compared the two murine splice variants with respect to
sensitivity to gating by ADP-ribosylation in transfected HEK cells.
Our results demonstrate that P2X7(k) but not P2X7(a) is sensitive
to gating by ADP-ribosylation. Moreover, we show that naive and
regulatory T cells preferentially express the more sensitive P2X7(k)
variant, whereas macrophages express the less sensitive P2X7(a)
variant. Our results indicate that differential splicing of alternative
exons encoding the N-terminal cytosolic and transmembrane
domains of P2X7 dictate the sensitivity of different immune cells to
extracellular NAD+ and ATP.
Materials and Methods
Mice
C57BL/6 and BALB/c mice were obtained from Centre
d’Elevage Janvier or from The Jackson Laboratory. All animal
experiments have been conducted according to relevant national
and international guidelines and have been approved by the local
institutional ethic committees (Animal Care and Use Committee,
Figure 1. Schematic diagram of P2X7 splice variant and mutants analyzed in this study. The P2X7 (a) and (k) splice variants differ in the N-
terminal 42 (a) and 39 (k) amino acids composing the cytosolic N terminal domain and most of the first transmembrane domain (Tm1) [23]. A) The
connectivity of cysteine residues (in red) corresponds to that observed in the crystal structure of zebrafish P2X4 [27,28]. The localization of three
arginine (R) residues in the extracellular domain of P2X7 is indicated by blue diamonds (R125 - the site of ADP-ribosylation, R151 - part of the epitope
of mAb Hano44, and R276 - conferring a gain of function when mutated to lysine or alanine [8]). The localization of a natural allelic polymorphism in
the cytosolic domain that distinguishes C57BL/6 mice from BALB/c and wild-type mice is indicated by a blue diamond [18]. Potential glycosylation
sites are indicated by green triangles. B) Model of the crystal structure of P2X7(a) based on the 3D structure of zebra fish P2X4 with bound ATP (pdb
code 4dw1) [28]. ATP is indicated in orange, the three subunits of the homotrimer are colored in yellow, cyan, and magenta. The ADP-ribosylation site
(R125) is in blue. The binding site of mAb Hano44 (R151) is in black. The gain of function mutant (R276) is in red. Green and blue dashed lines indicate
the plane of the membrane and the non-rendered cytosolic domains, respectively. The last 11 of the 42 N-terminal amino acid residues that
distinguish splice variant (a) from P2X7(k) are in grey. The structure was modeled with the corresponding residues of P2X7(a). C) Amino acid sequence
alignment of the N-terminal cytosolic (blue) and Tm1 (red) domains of P2X7(a) and P2X7(k).
doi:10.1371/journal.pone.0041269.g001
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Behoerde fuer Soziales, Familie, Gesundheit und Verbrau-
cherschutz - Lebensmittelsicherheit und Veterinaerwesen – animal
permit number G08/067_ADP, and Comite´ re´gional d’e´thique en
expe´rimentation animale de Normandie, authorization number
N/03-11-09/22/11-12).
Preparation and Analysis of Primary Lymphocytes
Single-cell suspensions were prepared from lymph nodes and
spleens in cold (4uC) RPMI 1640 medium by gentle dissection and
passage through Nitex membrane (125-mm mesh, Tetko). Con-
ventional and regulatory T cells were purified with magnetic beads
as described previously [15,16] using the CD4 negative isolation
kit (Invitrogen) and positive selection using anti-CD25-conjugated
magnetic beads (Milteny Treg purification kit). Purity of T cell
subpopulations was always .95% as verified by FACS analyses.
Expression Vectors and Cell Transfections
Expression vectors for ART2.1, ART2.2, P2X7(a)276K, and
CD62L were cloned as described previously [18,22,23,24]. The
expression construct for monomeric red fluorescent protein
(mRFP) was from Clontech Laboratories Inc. (Palo Alto, CA,
USA). P2X7(a) and P2X7(k) constructs were subcloned into the
pCDNA3.1 vector (Invitrogen, Karlsruhe, Germany). The 451P
mutation was introduced by site directed mutagenesis. For patch
clamp analysis, P2X7 variants were subcloned into a modified
(addition of a second CMV promoter from the pAdTrackCMV
vector [25] pTurbo FP635-N vector (Evrogen, Moscow, Russia),
to co-express mRFP as a transfection marker. For patch clamp
analysis, cells were transfected with 1 mg DNA/well on six-well
plate using lipofectamin (Invitrogen). For FACS analyses and live
cell imaging, cells were transfected in solution with 2.5 mg DNA
for cell surface antigens and 0.5 mg DNA for mRFP per 106 cells
using the jetPEI transfection reagent (Q-Biogen, Illkirch, France)
before plating onto T25 flasks or cover slips.
Antibodies and FACS Analyses
The monoclonal anti-P2X7 antibody Hano44, generated by
genetic immunization as described previously [26], was conjugated
to Alexa488 or Alexa647 (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instructions. HEK cells were
harvested by trypsinization 20–48 h post-transfection. Cells were
washed and then incubated in the absence or presence of the
indicated concentrations of NAD+ or ATP in DMEM medium
containing 1 mM DTT for 60 min at 37uC. Cells were washed
and stained with Alexa488, Alexa647 or PE-conjugated antibodies
(0.5 mg/26105 cells/100 ml) and Pacific Orange (PacO, Molecu-
lar Probes) for 20 min at 4uC. All measurements were performed
on a FACS-Calibur (BD, Franklin Lakes, NJ, USA) and analyzed
with the FlowJo software.
Ca2+ Imaging by Fluorescence Microscopy
Ratiometric Ca2+ imaging was essentially performed as de-
scribed previously [8,9]. In short: 20h post co-transfection of HEK
cells with expression vectors for P2X7, ART2.2, and mRFP cells
were loaded with the ratiometric Ca2+ indicator Fura-2 (Calbio-
chem, EMD Biosciences Inc., San Diego, CA, USA). After
loading, cells were subjected to Ca2+ imaging using imaging system
consisting of a Leica DM-IRBE fluorescence microscope with
a 40x objective (1.3 numerical aperture), a monochromator system
(polychromator II; TILL Photonics, Graefelfing, Germany) as
a light source, and a grayscale CCD camera (type C4742–95-
12NRB; Hamamatsu, Enfield, UK). During the experiments, cells
were continuously perfused with prewarmed (37uC) buffer
(15 mM HEPES, pH 7.4, 140 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 1.35 mM CaCl2, 10 mM glucose, 0.1% BSA) containing
the indicated concentrations of ATP or NAD using a perfusion
system from Warner Instruments (Hamden, CT, USA). Every 5 s
two images were taken at excitation wavelengths of 340 and
380 nm. For calculation of ratio images (340/380 nm) and
analysis Openlab software (v3.09; Improvision, Tu¨bingen, Ger-
many) was used.
Whole Cell Patch Clamping
Whole cell patch clamp recordings from transiently transfected
cells were performed at room temperature as previously described
[23] using an EPC9 amplifier and Pulse acquisition software
(HEKA, Lambrecht, Germany). Patch pipettes (2–3 MV) were
pulled from Corning 0010 glass (WPI, Sarasota, FL). The pipette
solution contained 147 mM NaCl, 10 mM HEPES, and 10 mM
EGTA. During the recording, cells were constantly perfused with
Figure 2. The P2X7(a) splice variant shows two-fold higher cell surface expression levels in transfected HEK cells than the P2X7(k)
variant. HEK cells were co-transfected with expression constructs for mRFP and P2X7(a) (upper panels) or P2X7(k) lower panels. A) P2X7 splice
variants carrying the 451L allele found in C57BL/6 mice; B) P2X7 splice variants carrying the 451P allele found in BALBc mice. FACS-analyses of native
P2X7 on the surface of HEK cells were performed 20 h after transfection using Alexa647-conjugated monoclonal antibody Hano44 (shaded
histograms) or an isotype control (open histograms) [26]. Gating was performed on all cells (left panels) or on mRFP-positive cells. Numbers indicate
mean fluorescent intensities of P2X7 staining. Results are representative of four independent experiments.
doi:10.1371/journal.pone.0041269.g002
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extracellular solution containing 147 mM NaCl, 2 mM KCl,
2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 13 mM
glucose. Both solutions were adjusted with NaOH to pH 7.3–
7.35 and 300–310 mosmol/kg. The membrane potential was
clamped at -70 mV. Agonist-containing solutions were automat-
ically applied with slight pressure via an automated valve system
(Nanion, Munich, Germany) and a manifold (ALA Scientific
Instruments, Farmingdale, NY) positioned above the cell. To
account for the observed sensitization and run down of P2X7
receptor currents, data were collected after obtaining stable
responses to 300 mM ATP (Fluka); this concentration was also
applied as a reference concentration immediately after application
of each test concentration. EC50 values were calculated from
a non-linear fit of the Hill equation to the data using Origin 7.5
software (Origin- Lab Corp., Northampton, MA). Data points are
presented as mean 6 S.E. from 3–8 cells.
Quantitative Real Time PCR
Total RNA was prepared from using either TRIzol (Invitrogen)
for muscle samples or RNAqueousH Kit (Invitrogen) for purified
macrophages and T cells. Equivalent amounts of RNA were
reverse transcribed using random hexamers (Superscript first
strand synthesis system for RT-PCR, Invitrogen). Reverse
transcriptase was omitted in negative controls. PCR on mouse
cells was performed with primers specific to exon one of P2X7(a)
and P2X7(k), respectively (59- CAC ATG ATC GTC TTT TCC
TAC - 39) and (59-GCC CGT GAG CCA CTT ATG C -39) [23].
Antisense primers targeting the common exon 2 were chosen to
match each specific forward primer and to give optimal PCR
amplification. The chosen antisense primer for detection of
P2X7(a) and P2X7(k) were, respectively, (59-CCT GCA AAG
GGA AGG TGT AG-39) and (59-CCC ACC CTC TGT GAC
ATT CT-39). The qPCR reaction mixtures were set-up in glass-
capillaries using 2 ml cDNA template and the reaction mixture
recommended by the kit supplier (FastStart DNA Master SYBR
Green I, Roche). The amplification conditions were 40 cycles of
95uC for 10s, 60uC for 10s, and 72uC for 10s using a real time
cycler (lightCyclerH, Roche). The relative amount of P2X7
variants mRNA for each sample was then normalized against
the eEF2 house keeping gene mRNA amount and quantified in
arbitrary units by comparison to serial dilution of reference
plasmids containing the cloned PCR products. The identity of the
PCR products was confirmed by gel analysis and/or sequencing.
Statistical Analysis
All data are shown as mean values and error bars represent
SEM. For statistical comparisons, one-way analysis of variance
(ANOVA) and Tukey’s post-hoc tests were used. Differences were
considered to be statistically significant when p-values were,0.05.
All calculations were performed using Prism 5.04 software (Graph-
Pad Software, Inc.).
3D Modeling
The 3D structure of mouse P2X7 was modeled on the recently
published structure of zebrafish P2X4 [27,28] using Swiss model
(URL http://swissmodel.expasy.org).
Results and Discussion
In Transfected HEK Cells P2X7(a) Shows Two-fold Higher
Cell Surface Expression Levels than P2X7(k)
The availability of a monoclonal antibody recognizing P2X7
in native conformation [26,29] allows direct quantification of
P2X7 exposed on the surface of individual living cells. Western-
Blot analyses, in contrast, only provide information about total
P2X7 protein levels in a population of cells. In order to assess
Figure 3. P2X7(k) shows higher sensitivity to gating by ATP than P2X7(a). HEK cells transfected with the indicated P2X7 constructs were
analyzed 1–3 days after transfection and clamped at -70 mV [23]. (A) Comparison of dose response curves for ATP. The values of the test
concentrations were calculated in reference to the value obtained with a 300 mM reference concentration that was given immediately before or after
the test concentration. Dose response curves were fit to the Hill equation and subsequently normalized to their maximal values. The following EC50
values and Hill coefficients were obtained: P2X7(k)451L: 6364 mM, P2X7(a)276K: 6164 mM, P2X7(a)451P: 338689 mM, and P2X7(a)451L 2926117 mM
(n=3–8 for each data point). (B) Representative current traces and recording protocol for the dose response analysis. The indicated test
concentrations and a 300 mM reference concentration of ATP were consecutively applied to account for run-up/run-down of receptor currents during
the experiment. Results are representative of four independent experiments.
doi:10.1371/journal.pone.0041269.g003
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cell surface expression of the P2X7 splice variants, we
transiently transfected HEK cells with cDNA expression
constructs and monitored cell surface expression of the P2X7
isoforms by FACS using monoclonal antibody Hano44 that
detects a common epitope (encompassing residue R151) on both
splice variants (Fig. 2) [8,26]. The efficiency of transfection was
monitored by co-transfection with mRFP. While transfection
efficiencies were similar for both variants, the mean fluorescence
intensities of HEK cells transfected with P2X7(a) (Fig. 2, upper
panels) were consistently approximately two-fold higher than
those of cells transfected with P2X7(k) (Fig. 2, lower panels),
regardless of whether the splice variants carried the 451 allele
found in C57BL/6 (451L) (Fig. 2A) or that found in BALBc
mice (451P) (Fig. 2B) [18]. The results indicate that assembly
and transport to the cell surface of the P2X7(a) variant is more
efficient than that of the P2X7(k) variant.
In Transfected HEK Cells, the P2X7(k) Variant Shows
a Five-fold Higher Sensitivity to ATP-Induced Gating than
the P2X7(a) Variant
Using whole cell patch clamp recordings of HEK cells
transfected with splice variants of rat P2X7, we have previously
observed that cells expressing P2X7(k) were 8-fold more
sensitive to the agonist Bz-ATP and displayed much slower
deactivation kinetics than cells expressing P2X7(a) [23]. In order
to assess gating of the mouse P2X7 splice variants, HEK cells
transfected with mouse P2X7(a) and P2X7(k) constructs were
analyzed 1 to 3 days after transfection and clamped at 270 mV
[23] (Fig. 3). Upon application of 300 mM ATP, both variants
were rapidly activated and reached a constant current within
4 s (Fig. 3B). In contrast to the previously described rat variants,
both variants quickly inactivated after removal of the agonist.
Dose-response analysis revealed a five-fold higher sensitivity of
the P2X7(k) variant for ATP (EC50 60 mM) than the P2X7(a)
variant (EC50 300 mM) (Fig. 3A). The previously described
R276K gain of function mutant of P2X7(a) [8] also displayed
an increased ATP-sensitivity (EC50 60 mM), similar to that of
the P2X7(k) variant.
ADP-ribosylation of the P2X7(k) but not the P2X7(a)
Variant Induces Stable Ca2+ Signals
We previously noticed that HEK cells co-transfected with
P2X7(a) and ART2.2 did not show any Ca2+ influx in response to
treatment with NAD+, but did respond to very high concentrations
of extracellular ATP (1 mM) [8,9]. In striking contrast, the
P2X7(a) R276K mutant showed vigorous responses to low
concentrations of NAD+ [8,9]. In order to determine whether
ADP-ribosylation could gate the P2X7(k) variant, we analyzed free
cytosolic Ca2+ concentrations in HEK cells loaded with the Ca2+
sensitive fluorophore Fura-2 48 h after co-transfection with
ART2.2 and P2X7 by live cell imaging (Fig. 4). Cells were
perfused with increasing concentrations of NAD+ or ATP for
three-minute intervals, followed by a wash-out of the nucleotide.
Consistent with previous observations [8,22], P2X7(a)/ART2.2
Figure 4. ADP-ribosylation of P2X7(k) induces stable Ca2+ signals. HEK cells were co-transfected with expression constructs for mRFP,
ART2.2, and the indicated splice variants of P2X7. 20 h post transfection, cells were loaded with the Ca2+-sensitive fluorophore Fura-2 before live-cell
imaging by fluorescence microscopy at 37uC [8]. Images were captured every 5 sec. At the indicated times, the perfusion buffer was changed to
perfuse cells with increasing doses of NAD+ (panels 1–3) or ATP (panels 4–6). Ratio images (340/380 nm) were constructed pixel-by-pixel and single
cell tracings were obtained using the Openlab software. Grey lines show single cell tracings, red lines the calculated mean. Results are representative
of two independent experiments.
doi:10.1371/journal.pone.0041269.g004
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co-transfected HEK cells did not show any detectable responses,
even to very high concentrations of NAD+ (Fig. 4, panel 2). In
striking contrast, HEK cells co-transfected with P2X7(k) and
ART2.2, responded with stable Ca2+ signals upon perfusion with
NAD+ concentrations above 30 mM (Fig. 4, panel 3). Similarly,
HEK cells transfected with the P2X7(k) variant showed detectable
but submaximal responses to 300 mM ATP, while P2X7(a)
transfected cells showed responses only at very high levels of
ATP (3 mM) (Fig. 4, panels 5, 6). Remarkably, while wash out of
ATP was followed by a gradual decrease of Ca2+-induced
fluorescence in case of P2X7(a)-transfected cells (Fig. 4, panel 5),
Ca2+-induced fluorescence remained at high levels for more than 3
minutes after wash out of the agonist in case of P2X7(k)-
transfected cells (Fig. 4, panel 6), possibly reflecting sustained
channel opening or intracellular redistribution of the Ca2+ sensor,
Fura-2.
ADP-ribosylation of P2X7(k) Induces Permeabilization of
the Cell Membrane to the Amine-reactive Dye Pacific
Orange (PacO)
Activation of P2X7 on naive T cells following treatment with
extracellular NAD+ induces a rapid ART2- and P2X7-de-
pendent externalization of phosphatidylserine, and ultimately,
cell death [17,30]. Amine-reactive dyes are convenient dyes for
dead cell discrimination by flow cytometry [31]. These dyes
covalently bind to amine groups on proteins. On live cells, only
membrane proteins are accessible to these dyes, resulting in dim
fluorescence. On cells with damaged membranes, however,
these dyes can enter cells and cause an up to fifty-fold increase
in fluorescence. In order to assess whether NAD+ treatment can
induce the uptake of the 750 Dalton amine-reactive dye PacO,
we analyzed HEK cells co-transfected with ART2.1 and P2X7
splice variants (Fig. 5). A substantial fraction of cells transfected
with P2X7(k) responded to NAD+ treatment with increased
staining by PacO in a concentration-dependent manner
(Fig. 5A). In contrast, cells transfected with P2X7(a) did not
show a detectable PacO uptake in response to NAD+ (Fig. 5A
top panels). In this assay, the R276K gain of function mutant
showed much stronger responses to both NAD+, and ATP than
P2X7(k) (Fig. 5 A, B, lower panels).
ADP-ribosylation of P2X7(k) Induces Shedding of L-
selectin (CD62L)
Treatment of naive T cells with extracellular NAD+ induces the
ART2- and P2X7-dependent shedding of CD62L by an ADAM-
like metalloprotease [17,30]. In order to assess whether the
ART2.P2X7. ADAM . CD62L axis could be reconstituted in
HEK cells, we co-transfected cells with ART2.1, P2X7 and
CD62L (Fig. 6). FACS analyses confirmed robust co-expression of
ART2.1, P2X7 and CD62L 40 h after transfection (Fig. 6A,
panels 1, 4, 7, 8). Remarkably, cells transfected with P2X7(k)
responded to NAD+ treatment with loss of CD62L from the cell
surface in a concentration-dependent manner (IC50 4 mM)
(Fig. 6B). Similarly, these cells showed concentration-dependent
down-modulation of P2X7 itself (Fig. 6A, panels 4–6). In striking
contrast, cells transfected with P2X7(a) did not show any
detectable shedding of CD62L in response to NAD+ (Fig. 6A
panels 1–3). Consistently, HEK cells transfected with the P2X7(k)
variant showed a higher sensitivity to ATP-induced shedding of
CD62L (IC50 30 mM vs. 180 mM) (Fig. 6C). Again, the sensitivity
of the P2X7(k) variant to both, NAD+ and ATP, was similar to
that of P2X7(a) carrying the R276K gain of function mutation
(Fig. 6 B, C).
Figure 5. ADP-ribosylation of P2X7(k) induces permeabilization of the cell membrane to the amine-reactive dye PacO. HEK cells were
co-transfected with expression constructs for ART2.1 and the indicated splice variants of P2X7, harvested 48 post transfection, and incubated for
30 min in the presence of the indicated concentrations of NAD+ (A) or ATP (B) as in Fig. 3. Cells were stained with Alexa647-conjugated anti-P2X7
(Hano44) and amine-reactive Pacific Orange (PacO) and subjected to FACS-analyses. Similar results were obtained with constructs on the BALBc
background (451P). Results are representative of two independent experiments.
doi:10.1371/journal.pone.0041269.g005
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Figure 6. ADP-ribosylation of P2X7(k) induces shedding of CD62L. HEK cells were co-transfected with expression constructs for ART2.1,
CD62L, and the indicated splice variants of P2X7 [8]. Cells were harvested 48h after transfection by gentle trypsinization, washed and incubated for
30 min at 37uC in the presence of the indicated concentrations of NAD+ or ATP before staining with Alexa647-conjugated anti-P2X7 (Hano44),
Alexa488-conjugated anti-ART2.1 (R18A22), and PE-conjugated anti-CD62L (MEL-14) and FACS-analyses. Similar results were obtained with constructs
harboring the 451P allele found in BALBc mice. Results are representative of four independent experiments.
doi:10.1371/journal.pone.0041269.g006
Figure 7. P2X7(k) is the dominant transcript in T cells, P2X7(a) is the dominant transcript in macrophages and muscle cells. Total
RNA was prepared from primary splenic and lymph node T cells, peritoneal macrophages, and skeletal muscle tissue from C57BL/6 mice (carrying the
451L allelic variant of P2X7). RNA samples were subjected to quantitative RT-PCR analyses with primers specific to exon one of P2X7(a) or P2X7(k) [23].
Results are representative of four independent experiments for lymphocytes and three independent experiments for macrophages and skeletal
muscle. Error bars represent SEM. *, p,0.05; ***, p,0.001.
doi:10.1371/journal.pone.0041269.g007
ADP-Ribosylation Gates the P2X7(k) Splice Variant
PLoS ONE | www.plosone.org 7 July 2012 | Volume 7 | Issue 7 | e41269
P2X7(k) is the Dominant Transcript in Conventional and
Regulatory T Cells, P2X7(a) is the Predominant Transcript
in Macrophages and Muscle Cells
Given the high sensitivity of P2X7(k) and the insensitivity of
P2X7(a) towards NAD+ in transfected HEK cells, we wondered
whether differential splicing might be used in vivo to govern the
differential response of different cell types to activation by ATP
and NAD+-dependent ADP-ribosylation. To address this question
we performed quantitative RT-PCR analyses on purified T cell
subsets and macrophages using splice variant-specific PCR
primers (Fig. 7). The results show that T cells contain 20-30-
fold higher copy numbers of P2X7(k) vs. P2X7(a) transcripts.
Remarkably, the reverse holds true for macrophages and muscle
cells that contain 30-50-fold higher copy numbers of the less
sensitive P2X7(a) transcripts. The higher transcript numbers of
P2X7 in regulatory vs. conventional T cell subsets correlates with
the previously observed higher sensitivity of Tregs to extracellular
ATP and NAD+ [14,15].
Conclusions
In this study, we compared the sensitivities of P2X7 splice
variants differing in the N-terminal cytosolic-Tm1 domain to
gating by ATP and NAD+-dependent ADP-ribosylation using
HEK cells transfected with the ART2 ecto-enzymes and P2X7
splice variants. Our results show that ADP-ribosylation activates
the P2X7(k) variant, inducing influx of Ca2+, shedding of CD62L,
and permeabilization of cells to 750 Da amine-reactive dyes. The
P2X7(a) variant, in contrast is insensitive to activation by ADP-
ribosylation. The differential sensitivities toward NAD+ are
mirrored by similar differential sensitivities to activation by ATP.
The finding that P2X7(k) responds more vigorously than P2X7(a)
(Figs. 3–6) despite lower expression on the cell surface (Fig. 2)
suggests that the composition and structure of the N-terminus of
P2X7 is more important for gating sensitivity than receptor density
on the cell surface. An alternative splice variant lacking the C-
terminal tail was recently described for human P2X7 [32]. It will
be interesting to determine whether the mouse can generate an
isoform lacking the C-terminal tail similar to human P2X7(B) and
whether the human can generate an isoform with an alternative N-
terminus similar to mouse P2X7(k).
Interestingly, the P2X7(a) variant can be rendered sensitive to
gating by ADP-ribosylation by site-directed replacement of a single
amino acid residue (R276) at a considerable distance outside of the
transmembrane domain [8] (Figs. 5, 6). This residue 276 is located
at the interface of neighboring subunits approximately halfway
between the ADP-ribosylation site and the transmembrane
domains (Fig. 1B). It is tempting to speculate that allosteric
modulators may similarly render the P2X7(a) variant sensitive to
gating by ADP-ribosylation under (patho)physiological conditions.
We conclude that the composition of the N-terminal cytosolic
and first transmembrane domain control gating of P2X7 by ADP-
ribosylation in transfected HEK cells. Our results further
demonstrate that T cells preferentially express the P2X7(k) variant
while macrophages preferentially express the less sensitive P2X7(a)
variant. These findings correlate with the previously observed
differential sensitivities of these cells to extracellular ATP and
NAD+ [22]. As the P2X7(k) variant escapes gene deletion in the
Glaxo P2X72/2 mice [23], these results also explain why T cells
were still found to be sensitive to ATP in these mice while
macrophages were rendered insensitive by the same genetic
deletion [33]. We conclude that alternative splicing of P2X7
governs the sensitivity of cells to gating of P2X7 by ADP-
ribosylation and by ATP.
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